P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 198 400 KRW -0.8% Market Closed
Market Cap: 2.1T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Interest Income Expense
â‚©13.8B
CAGR 3-Years
53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Interest Income Expense
-â‚©13B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Interest Income Expense
â‚©19.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Interest Income Expense
-â‚©49.9B
CAGR 3-Years
-158%
CAGR 5-Years
-79%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Interest Income Expense
â‚©9.8B
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Interest Income Expense
â‚©8B
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
No Stocks Found

PharmaResearch Co Ltd
Glance View

Market Cap
2T KRW
Industry
Biotechnology

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Intrinsic Value
248 805.39 KRW
Undervaluation 20%
Intrinsic Value
Price
P

See Also

What is PharmaResearch Co Ltd's Interest Income Expense?
Interest Income Expense
13.8B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Interest Income Expense amounts to 13.8B KRW.

What is PharmaResearch Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
53%

Over the last year, the Interest Income Expense growth was 1 337%. The average annual Interest Income Expense growth rates for PharmaResearch Co Ltd have been 53% over the past three years .

Back to Top